Blair William & Co. IL Has $156.18 Million Holdings in Procter & Gamble Company (The) $PG

Blair William & Co. IL decreased its holdings in Procter & Gamble Company (The) (NYSE:PG) by 1.0% in the 2nd quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 980,263 shares of the company’s stock after selling 9,917 shares during the quarter. Blair William & Co. IL’s holdings in Procter & Gamble were worth $156,175,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also recently made changes to their positions in PG. Kingstone Capital Partners Texas LLC raised its position in shares of Procter & Gamble by 655,209.0% in the second quarter. Kingstone Capital Partners Texas LLC now owns 76,028,952 shares of the company’s stock valued at $11,832,680,000 after buying an additional 76,017,350 shares in the last quarter. Nuveen LLC bought a new position in Procter & Gamble during the 1st quarter worth $1,954,941,000. Price T Rowe Associates Inc. MD raised its holdings in Procter & Gamble by 13.0% in the 1st quarter. Price T Rowe Associates Inc. MD now owns 21,480,670 shares of the company’s stock valued at $3,660,737,000 after acquiring an additional 2,466,308 shares in the last quarter. Invesco Ltd. lifted its position in shares of Procter & Gamble by 19.8% during the 1st quarter. Invesco Ltd. now owns 13,493,604 shares of the company’s stock valued at $2,299,580,000 after acquiring an additional 2,228,151 shares during the period. Finally, Valeo Financial Advisors LLC grew its holdings in shares of Procter & Gamble by 1,875.5% during the 2nd quarter. Valeo Financial Advisors LLC now owns 1,763,404 shares of the company’s stock worth $280,946,000 after purchasing an additional 1,674,139 shares in the last quarter. Institutional investors and hedge funds own 65.77% of the company’s stock.

Insider Buying and Selling

In other news, CFO Andre Schulten sold 11,638 shares of the firm’s stock in a transaction on Tuesday, August 19th. The shares were sold at an average price of $157.27, for a total transaction of $1,830,308.26. Following the completion of the transaction, the chief financial officer owned 52,642 shares of the company’s stock, valued at approximately $8,279,007.34. This trade represents a 18.11% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, insider Marc S. Pritchard sold 9,849 shares of the business’s stock in a transaction on Tuesday, August 19th. The stock was sold at an average price of $157.27, for a total transaction of $1,548,952.23. Following the completion of the sale, the insider directly owned 182,422 shares in the company, valued at approximately $28,689,507.94. This represents a 5.12% decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 149,763 shares of company stock valued at $23,421,279 over the last three months. Insiders own 0.20% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of research analysts recently commented on the company. JPMorgan Chase & Co. reaffirmed a “neutral” rating and issued a $170.00 price target (down previously from $178.00) on shares of Procter & Gamble in a research note on Friday, July 25th. UBS Group decreased their target price on shares of Procter & Gamble from $180.00 to $176.00 and set a “buy” rating on the stock in a report on Wednesday. Wells Fargo & Company cut their price target on shares of Procter & Gamble from $173.00 to $170.00 and set an “overweight” rating for the company in a report on Thursday, September 25th. BNP Paribas Exane reduced their price target on shares of Procter & Gamble from $177.00 to $172.00 and set an “outperform” rating on the stock in a research report on Tuesday, September 23rd. Finally, Weiss Ratings restated a “hold (c+)” rating on shares of Procter & Gamble in a research report on Wednesday. Eleven research analysts have rated the stock with a Buy rating and nine have given a Hold rating to the stock. According to MarketBeat, Procter & Gamble presently has an average rating of “Moderate Buy” and a consensus price target of $172.58.

Procter & Gamble Stock Performance

NYSE PG opened at $150.53 on Friday. The firm’s fifty day moving average price is $155.26 and its two-hundred day moving average price is $159.62. The stock has a market cap of $352.31 billion, a PE ratio of 23.12, a PEG ratio of 4.00 and a beta of 0.36. The company has a debt-to-equity ratio of 0.49, a quick ratio of 0.49 and a current ratio of 0.70. Procter & Gamble Company has a fifty-two week low of $149.58 and a fifty-two week high of $180.43.

Procter & Gamble (NYSE:PG) last released its quarterly earnings data on Tuesday, July 29th. The company reported $1.48 earnings per share for the quarter, beating the consensus estimate of $1.42 by $0.06. Procter & Gamble had a return on equity of 32.69% and a net margin of 18.95%.The company had revenue of $20.89 billion for the quarter, compared to the consensus estimate of $20.79 billion. During the same quarter last year, the business posted $1.40 EPS. Procter & Gamble’s revenue for the quarter was up 1.7% on a year-over-year basis. Procter & Gamble has set its FY 2026 guidance at 6.830-7.090 EPS. On average, equities analysts expect that Procter & Gamble Company will post 6.91 EPS for the current fiscal year.

Procter & Gamble Profile

Procter & Gamble Co engages in the provision of branded consumer packaged goods. It operates through the following segments: Beauty, Grooming, Health Care, Fabric and Home Care, and Baby, Feminine and Family Care. The Beauty segment offers hair, skin, and personal care. The Grooming segment consists of shave care like female and male blades and razors, pre and post shave products, and appliances.